$3.815
-0.176 (-4.62%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BOLT Prediction & Forecast by Similar Chart Analysis
Alphio's BOLT stock price prediction model matches the current Bolt Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.77 (-1.15%). The 1-week path is $3.88 (+1.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics Inc is a good buy right now due to its strong potential in the biotherapeutics space, highlighted by a recent analyst price target of $22, which suggests significant upside from the current price of $3.81. Additionally, the stock has an RSI of 57.134, indicating it is not overbought and may have room for growth. However, investors should be cautious of the recent earnings miss, with a reported EPS of -4.57, which was worse than the estimate of -2.97, reflecting ongoing operational challenges.
BOLT stock price ended at $3.82 on Friday, after losing -4.62%
Bolt Biotherapeutics, Inc. (BOLT) last closed at $3.815, losing -4.62%. These facts feed the 1-day and 1-week BOLT price prediction above.
Forecast Drivers
Bolt Biotherapeutics, Inc. (BOLT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BOLT, ranked by similarity.
Seasonality analysis for BOLT
Historically the probability of a positive August return for BOLT is 0.00%. January offers the highest probability of a positive month at 44.26%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BOLT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.14 | $0.16 | $0.19 | -95.80% |
| Sep 2026 | $0.11 | $0.13 | $0.14 | -96.56% |
| Oct 2026 | $0.13 | $0.15 | $0.18 | -96.09% |
| Nov 2026 | $0.15 | $0.16 | $0.17 | -95.78% |
| Dec 2026 | $0.10 | $0.13 | $0.14 | -96.56% |
In 2026, Bolt Biotherapeutics, Inc. (BOLT) is projected to range from $0.10 to $0.19.
Bolt Biotherapeutics, Inc. 2026 monthly forecast
In Aug 2026, Bolt Biotherapeutics, Inc. is projected to average $0.16, with a low of $0.14 and high of $0.19.
In Sep 2026, Bolt Biotherapeutics, Inc. is projected to average $0.13, with a low of $0.11 and high of $0.14.
In Oct 2026, Bolt Biotherapeutics, Inc. is projected to average $0.15, with a low of $0.13 and high of $0.18.
In Nov 2026, Bolt Biotherapeutics, Inc. is projected to average $0.16, with a low of $0.15 and high of $0.17.
In Dec 2026, Bolt Biotherapeutics, Inc. is projected to average $0.13, with a low of $0.10 and high of $0.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.